KBC Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.7M Buy
42,852
+26,206
+157% +$6.95M 0.04% 278
2026
Q1
$1.82M Buy
16,646
+1,030
+7% +$147K ﹤0.01% 667
2025
Q4
$2.6M Buy
15,616
+11,934
+324% +$2M 0.01% 567
2025
Q3
$721K Buy
3,682
+174
+5% +$28.6K ﹤0.01% 687
2025
Q2
$317K Buy
+3,508
New +$277K ﹤0.01% 753
2025
Q1
Sell
-1,504
Closed -$199K 1896
2024
Q4
$199K Buy
+1,504
New +$141K ﹤0.01% 1129

Other funds holding ALAB

KBC Group's ALAB Position: Q2 2026 in Review

KBC Group increased its Astera Labs (ALAB) stake by 157% in Q2 2026, buying an estimated $6.95M and bringing the position to 42,852 shares worth $20.7M. The position accounts for 0.04% of the portfolio, ranked #278.

KBC Group first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. 991 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • KBC Group held 42,852 shares of Astera Labs worth $20.7M as of Q2 2026.
  • KBC Group bought 26,206 Astera Labs shares in Q2 2026, an estimated $6.95M.
  • Astera Labs made up 0.04% of KBC Group's portfolio in Q2 2026, its #278 holding.
  • KBC Group first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • 991 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.